Association and linkage disequilibrium analyses of APOE polymorphisms in atherosclerosis

Disease Markers

Volumn 24, Issue 2, 2008, Pages 65-72

  Artieda, Marta ^a   Gañán, Alberto ^b   Cenarro, Ana ^a   García Otín, Ángel Luis ^a   Jericó, Ivonne ^c   Civeira, Fernando ^a   Pocoví, Miguel ^b  

^a HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^b UNIVERSITY OF ZARAGOZA   (Spain)

^c Universidad Pública de Navarra   (Spain)

Author keywords

Apolipoprotein E; Atherosclerosis; Atherothrombotic stroke; Ischemic heart disease; Polymorphisms

Indexed keywords

APOLIPOPROTEIN E;

ADULT; AGED; ALLELE; APOE GENE; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; CAROTID ARTERY; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HUMAN; ISCHEMIC HEART DISEASE; LIPID METABOLISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; SCORING SYSTEM; SPAIN; STROKE;

EID: 38349116808     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/650410     Document Type: Article

References (36)

1. A. von Eckardstein, J.R. Nofer and G. Assmann, High density lipoproteins and arteriosclerosis: role of cholesterol efflux and reverse cholesterol transport, Arterioscler Thromb Vasc Biol 21 (2001), 13-27.
2. BARI protocol. Protocol for the Bypass Angioplasty Revascularization Investigation, Circulation 84(Suppl V) (1991), 1-27.
3. D. Corella, M. Guillen, O. Portoles et al., Polimorfismos en el gen de la apolipoproteína E y riesgo de hipercolesterolemia: un estudio de casos y controles en una población laboral de Valencia, Med Clin (Barc) 115 (2000), 170-175.
4. D. Gomez-Coronado, J.J. Alvarez, A. Entrala et al., Apolipoprotein E polymorphism in men and women from a Spanish population: allele frequencies and influence on plasma lipids and apolipoproteins, Atherosclerosis 147 (1999), 167-176.
5. D.R. Sullivan, T.H. Marwick and S.B. Freedman, A new method of scoring coronary angiograms to reflect extent of coronary atherosclerosis and improve correlation with major risk factors, Am Heart J 119 (1990), 1262-1267.
6. E.H. Corder, A.M. Saunders, W.J. Strittmatter et al., Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families, Science 261 (1993), 921-923.
7. G. Attila, E. Acarturk, G. Eskandari et al., Effects of apolipoprotein E genotypes and other risk factors on the development of coronary artery disease in Southern Turkey, Clin Chim Acta 312 (2001), 191-196.
8. G. Siest, T. Pillot, A. Regis-Bailly et al., Apolipoprotein E: an important gene and protein to follow in laboratory medicine, Clin Chem 41 (1995), 1068-1086.
9. G.M. Novarro, R. Sachar, G.L. Pearce et al., Association between apolipoprotein E alleles and calcific valvular heart disease, Circulation 108 (2003), 1804-1808.
10. H.P. Adams Jr, B.H. Bendixen, L.J. Kappelle et al., Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment, Stroke 24 (1993), 35-41.
11. I. Chen, M.R. Chester, S. Redwood et al., Rapid angiographic disease progression in patients with stabilised unstable angina, Circulation 91 (1995), 2319-2324.
12. J. Dallongeville, S. Lussier-Cacan and J. Davignon, Modulation of plasma triglyceride levels by apoE phenotype: a metaanalysis, J Lipid Res 33 (1992), 447-454.
13. J. Davignon, R.E. Gregg and C.F. Sing, Apolipoprotein E polymorphism and atherosclerosis, Arteriosclerosis 8 (1988), 1-21.
14. J.C. Lambert, T. Brousseau, V. Defosse et al., Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study, Hum Mol Genet 9 (2000), 57-61.
15. J.C. Long, R.C.Williams and M. Urbanek, An E-M algorithm and testing strategy for multiple-locus haplotypes, Am J Hum Genet 56 (1995), 799-810.
16. J.E. Hixson and D.T. Vernier, Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI, J Lip Res 31 (1990), 545-548.
17. J.M. de Bray and B. Glatt, Quantification of atheromatous stenosis in the extracranial internal carotid artery, Cerebrovasc Dis 5 (1995), 414-442.
18. L. Zurutuza, P. Verpillat, G. Raux et al., APOE promoter polymorphisms do not confer independent risk for Alzheimer's disease in a French population, Eur J Hum Genet 8 (2000), 713-716.
19. M. Artieda, A. Cenarro, A. Gañan et al., Serum chitotriosidase activity is increased in subjects with atherosclerosis disease, Arterioscler Thromb Vasc Biol 23 (2003), 1645-1652.
20. M. Margaglione, D. Seripa, C. Gravina et al., Prevalence of apolipoprotein E alleles in healthy subjects and survivors of ischemic stroke: an Italian Case-Control Study, Stroke 29 (1998), 399-403.
21. M. Muros and C. Rodriguez-Ferrer, Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4, Atherosclerosis 121 (1996), 13-21.
22. M. Pocoví, A. Cenarro, F. Civeira et al., Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136Ser) variant in multigenerational pedigree studies, Atherosclerosis 122 (1996), 33-46.
23. M.F. Reardon, P.J. Nestel, I.H. Graig et al., Lipoprotein predictors of the severity of coronary artery disease in men and women, Circulation 71 (1985), 881-888.
24. M.J. Artiga, M.J. Bullido, A. Frank et al., Risk for Alzheimer's disease correlates with transcriptional activity of the APOE gene, Hum Mol Genet 7 (1998), 1887-1892.
25. M.J. Artiga, M.J. Bullido, I. Sastre et al., Allelic polymorphisms in the transcriptional regulatory region of apolipoprotein E gene, FEBS Lett 421 (1998), 105-108.
26. P.J. Jeckins, R.W. Harper and P.J. Nestel, Severity of coronary atherosclerosis related to lipoprotein concentration, Br Med J 2 (1978), 388-391.
27. P.W. Wilson, E.J. Schaefer, M.G. Larson et al., Apolipoprotein E alleles and risk of coronary disease. A meta-analysis, Arterioscler Thromb Vasc Biol 16 (1996), 1250-1255.
28. R.L. Oliveri, G. Nicoletti, R. Cittadella et al., Apolipoprotein E polymorphisms and Parkinson's disease, Neurosci Lett 277 (1999), 83-86.
29. R.M. Corbo, R. Scacchi, T. Vilardo et al., Polymorphisms in the apolipoprotein E gene regulatory region in relation to coronary heart disease and their effect on plasma apolipoprotein E, Clin Chem Lab Med 39 (2001), 2-6.
30. R.W. Mahley, Apolipoprotein E: cholesterol transport protein with expanding role in cell biology, Science 240 (1988), 622-630.
31. S.W. Schwartz, L.E. Chambless, W.H. Baker et al., Consistency of Doppler parameters in predicting arteriographically confirmed carotid stenosis. Asymptomatic Carotid Atherosclerosis Study Investigators, Stroke 28 (1997), 343-347.
32. T. Budde, C. Fechtrup, E. Bosenberg et al., Plasma Lp(a) levels correlate with number, severity and length-extension of coronary lesions in male patients undergoing coronary arteriography for clinically suspected coronary atherosclerosis, Arterioscler Thromb 14 (1994), 1730-1736.
33. T. Mazzone, Apolipoprotein E secretion by macrophage: its potential physiological functions, Curr Opin Lipidol 7 (1996), 303-307.
34. W.J. Strittmatter, A.M. Saunders, D. Schmechel et al., Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease, Proc Natl Acad Sci USA 90 (1993), 1977-1981.
35. W.T. Friedewald, R.I. Levy and D.S. Fredrickson, Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge, Clin Chem 18 (1972), 499-502.
36. Y. Ji, K. Urakami, Y. Adachi et al., Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease, Dement Geriatr Cogn Disord 9 (1998), 243-245.